| Financial Year |
March 31 2020 |
| Monetary Funds |
1,110,441.36 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,781,474.50 |
| Accounts Receivable |
55,865,024.81 |
| Advances to Suppliers |
7,330,140.17 |
| Other Receivables |
2,220.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,913,372.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
544,268.83 |
| Total Current Assets |
69,546,942.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
16,000,000.00 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
497,904,648.84 |
| Under-construction Projects |
2,638,506.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
516,543,155.62 |
| Total Assets |
586,090,097.79 |
| Short-Term Loans |
231,491,699.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
271,546,706.86 |
| Accounts Received In Advance |
29,369,801.73 |
| Employee Compensation Payable |
1,147,136.34 |
| Taxes Payable |
1,676,599.24 |
| Interest Payable |
56,863,844.61 |
| Dividend Payable |
-- |
| Other payables |
186,691,996.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,936,606.64 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
762,860,547.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
34,745,968.32 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
34,745,968.32 |
| Total Liabilities |
797,606,515.33 |
| Paid-In Capital(Or Share Stock) |
275,000,000.00 |
| Capital Surplus |
519,405,265.08 |
| Surplus Reserve |
15,404,353.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,021,326,036.20 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-211,516,417.54 |
| Owner's Equity（Stockholder's Equity） |
-211,516,417.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
586,090,097.79 |
